Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer
Lumos Pharma
Lumos Pharma
Corcept Therapeutics
Hoffmann-La Roche
Astellas Pharma Inc
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
Celgene
Celgene
Celgene